Developed by Eli Lilly, this experimental drug targets multiple pathways in the body, setting it apart from other medications currently available
After months of screaming that compounding pharmacies do not report adverse events (by the way, 503Bs are legally required to report adverse events), Novo received a FDA Warning Letter this morning for not reporting adverse events
This feature is especially beneficial for researchers conducting repeated tests or experiments, eliminating contamination risks associated with repeated vial access
Safe review should include health history, medication review, side effect risk, weight-loss goals, hydration, nutrition, blood sugar monitoring, and provider-guided follow-up
[2] Liu, J., Head, E., Gharib, A
What to Avoid When Taking Glutathione